Mirnas as biomarkers for parkinson's syndrome
A technology for Parkinson's and syndromes, applied in the direction of microbial determination/testing, biological testing, biomaterial analysis, etc., can solve problems such as unmet clinical needs
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment approach
[0120] There are currently no standard blood or laboratory tests that have been shown to help diagnose Parkinson syndrome (PS), Parkinson disease (PD), or Parkinsonism or to help differentiate PD from Parkinsonism. Therefore, diagnosis is based on history and neurologic examination. Parkinsonism (PS), PD or Parkinsonism can be difficult to diagnose accurately. Doctors may sometimes order brain scans or lab tests to rule out other disorders. Currently, there is no cure for Parkinson's Syndrome (PS), PD, or Parkinson's disease, but a variety of medications can provide significant symptom relief. To overcome current barriers to better clinical trial design by improving the assessment of Parkinson's disease or Parkinson's progression across the disease spectrum, new diagnostic and progression biomarkers in PD or Parkinson's There is a pressing unmet need. The inventors identified miRNAs as biomarkers for Parkinson syndrome (PS), Parkinson disease (PD) and Parkinsonism. They al...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com